CLINICAL_TRIALS
trial_result
· 2019-01-23
Clinical Trial Update: Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus [Phase 2]
Summary
Phase 2 trial evaluating adjuvant radiation therapy with ifosfamide for mixed mesodermal tumors of the uterus has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Montefiore Medical Center | Conditions: Uterine Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-01-23